Dupont Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Dupont Capital Management's WST Position: Q3 2023 in Review
Dupont Capital Management sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 577 shares — an estimated $221K sold.
Dupont Capital Management first reported a position in WST in Q1 2016 and held it in 16 quarters. The position peaked at $3.28M in Q2 2020. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.
- Dupont Capital Management reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
- Dupont Capital Management sold 577 West Pharmaceutical shares in Q3 2023, an estimated $221K.
- Dupont Capital Management first reported a position in West Pharmaceutical in Q1 2016 and held it in 16 quarters.
- Dupont Capital Management's West Pharmaceutical position peaked at $3.28M in Q2 2020.
- 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.
Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.